MDS experts, Dr Alan List and Dr David Sallman, describe the treatment cycle for
azacitidine, a medication used for
myelodysplastic syndromes (
MDS). Treatment may be continued for as long as the patient continues to benefit. It is crucial that treatment decisions be made in consultation with your doctor, based on your personal situation.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.